Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy

被引：0
|
作者：
Shohei Takaichi
Yoshito Tomimaru
Shogo Kobayashi
Keisuke Toya
Kazuki Sasaki
Yoshifumi Iwagami
Daisaku Yamada
Takehiro Noda
Hidenori Takahashi
Tadafumi Asaoka
Masahiro Tanemura
Yuichiro Doki
Hidetoshi Eguchi
机构：
[1] Osaka University Graduate School of Medicine,Department of Gastroenterological Surgery
[2] Osaka Police Hospital,Department of Surgery
[3] Rinku General Medical Center,Department of Surgery
来源：
Annals of Surgical Oncology | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2458 / 2468
页数：10
相关论文
共 50 条
  • [31] Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy
    Pierluigi di Sebastiano
    Tommaso Grottola
    F. Francesco di Mola
    Updates in Surgery, 2016, 68 : 235 - 239
  • [32] Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma
    Tinchon, Christoph
    Hubmann, Eva
    Pichler, Angelika
    Keil, Felix
    Pichler, Martin
    Rabl, Hans
    Uggowitzer, Martin
    Jilek, Kurt
    Leitner, Gerhard
    Bauernhofer, Thomas
    ACTA ONCOLOGICA, 2013, 52 (06) : 1231 - 1234
  • [33] Letter to the editor: the nonnegligible effect of neoadjuvant therapy for patients with borderline resectable pancreatic ductal adenocarcinoma
    Wang, Li
    Zhang, Xin
    Lu, Yanrong
    Tian, Bole
    GLAND SURGERY, 2021, 10 (07) : 2340 - 2342
  • [34] Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
    Nakajima, Hiroki
    Yamaguchi, Junpei
    Takami, Hideki
    Hayashi, Masamichi
    Kodera, Yasuhiro
    Nishida, Yoshihiro
    Watanabe, Nobuyuki
    Onoe, Shunsuke
    Mizuno, Takashi
    Yokoyama, Yukihiro
    Ebata, Tomoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (05) : 688 - 697
  • [35] Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
    Hiroki Nakajima
    Junpei Yamaguchi
    Hideki Takami
    Masamichi Hayashi
    Yasuhiro Kodera
    Yoshihiro Nishida
    Nobuyuki Watanabe
    Shunsuke Onoe
    Takashi Mizuno
    Yukihiro Yokoyama
    Tomoki Ebata
    International Journal of Clinical Oncology, 2023, 28 : 688 - 697
  • [36] Is the Delphi's Oracle Pertinent to Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma? Reply
    Suurmeijer, J. Annelie
    Besselink, Marc G.
    van Laarhoven, Hanneke W. M.
    JAMA ONCOLOGY, 2022, 8 (12) : 1851 - 1852
  • [37] Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Bonds, Morgan
    Rocha, Flavio G.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [38] Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
    Janssen, Quisette P.
    O'Reilly, Eileen M.
    Van Eijck, Casper H. J.
    Groot Koerkamp, Bas
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection
    Kubo, Hirokazu
    Murakami, Takashi
    Matsuyama, Ryusei
    Yabushita, Yasuhiro
    Tsuchiya, Nobuhiro
    Sawada, Yu
    Homma, Yuki
    Kumamoto, Takafumi
    Endo, Itaru
    WORLD JOURNAL OF SURGERY, 2019, 43 (12) : 3153 - 3160
  • [40] Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Borderline Resectable Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgical Resection
    Hirokazu Kubo
    Takashi Murakami
    Ryusei Matsuyama
    Yasuhiro Yabushita
    Nobuhiro Tsuchiya
    Yu Sawada
    Yuki Homma
    Takafumi Kumamoto
    Itaru Endo
    World Journal of Surgery, 2019, 43 : 3153 - 3160
12345